회전근개 복구를 위한 줄기세포의 놀라운 진실 #회전근개 #PRP #BMAC

Ajouté : 2026-05-17

[00:00:00]A brand new study just dropped in Scientific Reports, a Nature journal, published May 2026, and the finding may surprise you Researchers ran a randomized controlled trial on 93 patients with large rotator cuff tears, 3-5 cm.

[00:00:15]They split them into 3 groups, repair alone, repair with PRP, and repair with BMAC plus PRP BMAC is bone marrow aspirate concentrate, packed with stem cells and growth factors, combined with PRP The theory is powerful, stack 2 biologics together and supercharge tendon healing But here is what actually happened At 6 months, after rigorous statistical adjustment, there was no significant difference between the 3 groups in pain scores, function scores, or overall shoulder outcome BMAC plus PRP did not outperform PRP alone, and PRP alone did not clearly outperform repair by itself Now before you write off biologics entirely, there is a critical detail buried in this paper When they looked at patients over age 55, the BMAC plus PRP group showed a trend toward better outcomes, it did not reach statistical significance after adjustment, but the signal was there And that makes clinical sense to me In my own practice repairing large and massive rotator cuff tears, I have seen that tissue quality matters more than tear size alone An older patient with degenerative tissue and poor vascularity, that is exactly the biology where concentrated stem cells and growth factors might tip the balance But here is the honest takeaway We cannot just layer biologics on top of each other and assume the effect adds up, biology does not work like stacking bricks What this study tells us is that we need smarter patient selection, not more products The future of biologic augmentation is matching the right biology to the right patient at the right time and I believe the next generation of tendon repair is about precision, not just more biology